Trader consensus on Polymarket reflects near-certainty that Anthropic will remain independent before 2027, driven by its aggressive expansion as an acquirer rather than acquisition target—recently snapping up stealth biotech startup Coefficient Bio for $400 million in April 2026 to bolster Claude's life sciences capabilities, following Vercept and Bun integrations. A fresh May 2026 joint venture with Blackstone, Goldman Sachs, and Hellman & Friedman injects $900 million-plus for enterprise AI deployment, signaling self-sustaining growth at a $350 billion-plus secondary valuation that prices out buyers. CEO Dario Amodei's firm stance amid Pentagon disputes reinforces autonomy, amid antitrust scrutiny on Big Tech AI deals involving existing Google and Amazon stakes. Realistic shifts could stem from unforeseen regulatory blocks on partnerships, a liquidity crunch forcing secondary sales, or surprise bids navigating FTC hurdles, though these face steep barriers with 18 months remaining.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · AtualizadoSim
$16,849 Vol.
$16,849 Vol.
Sim
$16,849 Vol.
$16,849 Vol.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mercado Aberto: Nov 12, 2025, 5:14 PM ET
Resolver
0x65070BE91...Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Trader consensus on Polymarket reflects near-certainty that Anthropic will remain independent before 2027, driven by its aggressive expansion as an acquirer rather than acquisition target—recently snapping up stealth biotech startup Coefficient Bio for $400 million in April 2026 to bolster Claude's life sciences capabilities, following Vercept and Bun integrations. A fresh May 2026 joint venture with Blackstone, Goldman Sachs, and Hellman & Friedman injects $900 million-plus for enterprise AI deployment, signaling self-sustaining growth at a $350 billion-plus secondary valuation that prices out buyers. CEO Dario Amodei's firm stance amid Pentagon disputes reinforces autonomy, amid antitrust scrutiny on Big Tech AI deals involving existing Google and Amazon stakes. Realistic shifts could stem from unforeseen regulatory blocks on partnerships, a liquidity crunch forcing secondary sales, or surprise bids navigating FTC hurdles, though these face steep barriers with 18 months remaining.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado
Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions